ebomi
Colour theme
Sign in
Insider · CIK 0001361754

Denner Alexander J

CIK 0001361754 Name as filed on the most recent filing

Filed as Denner Alexander J (38)

81 transaction lines · from 38 filings · filed 2012-01-19 to 2026-03-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

56 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-11-29 P, Open-market purchase Medicines Co /DEMDCO 5,105,100, acquired Open Form 4 filing 0000899243-17-027611
2017-11-28 P, Open-market purchase Biogen Inc.BIIB 6,322,400, acquired Open Form 4 filing 0000899243-17-027610
2017-08-31 P, Open-market purchase Apricus Biosciences, Inc.APRI 9,950, acquired Open Form 4 filing 0001140361-17-034162
2017-05-30 P, Open-market purchase Bioverativ Inc.BIVV 5,033,475, acquired Open Form 4 filing 0001127602-17-020070
2017-05-26 P, Open-market purchase Bioverativ Inc.BIVV 25,745,130, acquired Open Form 4 filing 0001127602-17-019588
2017-05-25 P, Open-market purchase Bioverativ Inc.BIVV 7,147,907, acquired Open Form 4 filing 0001127602-17-019588
2017-05-24 P, Open-market purchase Bioverativ Inc.BIVV 18,414,400, acquired Open Form 4 filing 0001127602-17-019588
2017-04-27 P, Open-market purchase Biogen Inc.BIIB 2 lines 20,569,476, acquired Open Form 4 filing 0001127602-17-016142
2016-03-03 P, Open-market purchase Apricus Biosciences, Inc.APRI 5,850,001, acquired Open Form 4 filing 0001140361-16-056843
2016-01-12 P, Open-market purchase Apricus Biosciences, Inc.APRI 1,150,001, acquired Open Form 4 filing 0001104659-16-089929
2015-10-23 P, Open-market purchase Biogen Inc.BIIB 27,677,000, acquired Open Form 4 filing 0000899243-15-007138
2015-10-22 P, Open-market purchase Biogen Inc.BIIB 58,338,000, acquired Open Form 4 filing 0000899243-15-007138
2014-08-15 P, Open-market purchase Ariad Pharmaceuticals IncARIA 2 lines 4,955,500, acquired Open Form 4 filing 0001127602-14-025958
2013-11-11 P, Open-market purchase Vivus IncVVUS 1,315,033, acquired Open Form 4 filing 0001104659-13-083704
2013-11-08 P, Open-market purchase Vivus IncVVUS 3,553,419, acquired Open Form 4 filing 0001104659-13-083704
2013-06-14 S, Open-market sale Biogen Idec Inc.BIIB 614,800, disposed Open Form 4 filing 0001127602-13-020492
2013-05-28 S, Open-market sale Biogen Idec Inc.BIIB 9 lines 9,135,697, disposed Open Form 4 filing 0001127602-13-018668
2012-12-27 S, Open-market sale Biogen Idec Inc.BIIB 2 lines 592,086, disposed Open Form 4 filing 0001127602-12-035115
2012-12-26 S, Open-market sale Biogen Idec Inc.BIIB 593,914, disposed Open Form 4 filing 0001127602-12-035115
2012-01-17 S, Open-market sale Amylin Pharmaceuticals IncAMLN 21,238, disposed Open Form 4 filing 0001264124-12-000017

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 40
  • Open-market sale 16
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DENNER ALEXANDER J, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001361754

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.